Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

STEWARD HOLY FAMILY HOSPITAL, INC.

NPI: 1336452010 · METHUEN, MA 01844 · Skilled Nursing Facility · NPI assigned 07/22/2010

Billing Flags · Automated signals — not evidence of fraud
Entity Proliferation

Authorized official RENNA, JAMES controls 11+ related entities in our dataset. Read more

$1.06M
Total Medicaid Paid
16,193
Total Claims
12,000
Beneficiaries
33
Codes Billed
2018-01
First Month
2024-02
Last Month

Provider Details

Authorized OfficialRENNA, JAMES (CHIEF FINANCIAL OFFICER)
Parent OrganizationSTEWARD HEALTH CARE SYSTEM LLC
NPI Enumeration Date07/22/2010

Related Entities

Other providers sharing the same authorized official: RENNA, JAMES

ProviderCityStateTotal Paid
STEWARD HOLY FAMILY HOSPITAL, INC. METHUEN MA $70.80M
STEWARD GOOD SAMARITAN MEDICAL CENTER, INC. BROCKTON MA $64.10M
STEWARD CARNEY HOSPITAL, INC. DORCHESTER CENTER MA $56.76M
STEWARD ST. ELIZABETH'S MEDICAL CENTER OF BOSTON, INC. BOSTON MA $32.53M
STEWARD NORWOOD HOSPITAL, INC. NORWOOD MA $8.47M
STEWARD ST. ELIZABETH'S MEDICAL CENTER OF BOSTON, INC. BOSTON MA $1.90M
NEW ENGLAND SINAI HOSPITAL, A STEWARD FAMILY HOSPITAL, INC. STOUGHTON MA $136K
STEWARD CARNEY HOSPITAL, INC. DORCHESTER CENTER MA $52K
STEWARD GOOD SAMARITAN MEDICAL CENTER, INC. BROCKTON MA $29K
MORTON HOSPITAL, A STEWARD FAMILY HOSPITAL, INC. TAUNTON MA $11K
STEWARD ST. ANNE'S HOSPITAL CORPORATION FALL RIVER MA $3K

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 3,101 $170K
2019 4,150 $236K
2020 3,078 $235K
2021 4,907 $345K
2022 824 $72K
2023 62 $0.00
2024 71 $5K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99285 Emergency department visit for the evaluation and management, high severity with immediate threat to life 1,215 900 $361K
99284 Emergency department visit for the evaluation and management, high severity 1,215 980 $298K
99283 Emergency department visit for the evaluation and management, moderate severity 1,194 988 $229K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance 541 422 $43K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 889 670 $26K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 243 202 $14K
96361 Intravenous infusion, hydration; each additional hour 347 262 $13K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 268 247 $12K
71046 Radiologic examination, chest; 2 views 262 208 $11K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 2,420 1,740 $9K
96375 Therapeutic injection; each additional sequential IV push 181 142 $6K
80053 Comprehensive metabolic panel 1,051 771 $6K
U0005 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 277 243 $5K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay 209 139 $5K
80048 Basic metabolic panel (calcium, ionized) 1,178 864 $5K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 152 121 $5K
71045 Radiologic examination, chest; single view 92 67 $4K
84484 522 302 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed 82 60 $2K
U0004 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r 32 32 $2K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 168 63 $1K
81001 745 588 $1K
84600 121 88 $1K
83690 169 134 $624.74
80076 113 96 $509.70
81025 115 99 $440.03
36415 Collection of venous blood by venipuncture 1,839 1,164 $324.35
J7030 Infusion, normal saline solution , 1000 cc 45 27 $287.00
81003 187 147 $170.05
J2405 Injection, ondansetron hydrochloride, per 1 mg 247 173 $105.22
87086 Culture, bacterial; quantitative colony count, urine 32 25 $77.14
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 14 12 $68.95
J1885 Injection, ketorolac tromethamine, per 15 mg 28 24 $38.90